Literature DB >> 21374752

Polypoid endometriosis of the bladder during pregnancy mimicking urachal carcinoma.

S Lambrechts1, K Van Calsteren, A Capoen, K Op De Beeck, S Joniau, D Timmerman, F Amant.   

Abstract

We report a case of polypoid bladder endometriosis in pregnancy. Diagnostic workup showed a vesicouterine well-vascularized polypoid mass, suspicious for malignancy. During pregnancy, the mass was surgically resected with safe oncological margins. Pathological examination of the resected specimen revealed pseudotumoral polypoid endometriosis of the bladder. We illustrate diagnostic pitfalls in the differentiation between bladder endometriosis during pregnancy and malignancy. As a result of pregnancy-related decidualization of vesical endometriosis, differentiation between this rare occurrence and malignant transformation is challenging.
Copyright © 2011 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21374752     DOI: 10.1002/uog.8985

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  3 in total

1.  MR findings of polypoid endometriosis of female genital organs: report of three cases.

Authors:  Ryo Yajima; Aki Kido; Sachiko Minamiguchi; Yusaku Moribata; Yasuhisa Kurata; Yuki Himoto; Satoshi Otani; Yuka Matsumoto; Akihito Horie; Ken Yamaguchi; Yuji Nakamoto
Journal:  Abdom Radiol (NY)       Date:  2022-05-06

2.  Loss of stromal CD73 expression plays a role in pathogenesis of polypoid endometriosis.

Authors:  Ali Yilmaz Altay; Ekrem Yavuz; Aysel Bayram; Cenk Yasa; Suleyman Engin Akhan; Samet Topuz; Semen Onder
Journal:  Arch Gynecol Obstet       Date:  2021-01-12       Impact factor: 2.344

Review 3.  Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.

Authors:  Henning Reis; Ulrich Krafft; Christian Niedworok; Orsolya Módos; Thomas Herold; Mark Behrendt; Hikmat Al-Ahmadie; Boris Hadaschik; Peter Nyirady; Tibor Szarvas
Journal:  Dis Markers       Date:  2018-03-12       Impact factor: 3.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.